# CLRB (Cellectar Biosciences, Inc.) - SEC EDGAR Financial Statements

> Cellectar Biosciences, Inc. reported $29.74M in total assets and a net loss of $25.85M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CLRB
- Markdown: https://convexityos.com/fundamentals/CLRB.md
- SEC CIK: 0001279704
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:06 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001279704&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$26.78M | Operating profit |
| Net Income | FY 2025 | -$25.85M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$1.48 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$23.12M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $24.58M | Total debt: $1.53M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $11.50M | $26.14M | $27.27M | $19.22M | $17.59M | $10.14M | $9.00M | $6.84M | $9.47M | $4.75M |
| **Operating Income** | -$22.98M | -$51.78M | -$38.96M | -$28.81M | -$24.13M | -$15.29M | -$14.18M | -$13.33M | -$13.60M | -$9.45M |
| **EBITDA** | -$22.77M | -$51.49M | -$38.77M | -$28.67M | -$23.98M | -$15.15M | -$14.05M | -$13.25M | -$12.05M | -$9.09M |
| Income Before Tax | -$21.79M | -$44.52M | -$42.83M | -$28.66M | -$24.12M | -- | -- | -- | -- | -- |
| Income Tax Expense | -- | $66K | -$60K | -$60K | -- | -- | $0 | $0 | $0 | $0 |
| **Net Income** | -$21.79M | -$44.58M | -$42.77M | -$28.60M | -$24.12M | -$15.09M | -$14.09M | -$13.24M | -$13.56M | -$6.18M |
| Basic EPS | -$8.35 | -$36.52 | -$105.11 | -$121.62 | -$130.63 | -$22.82 | -$55.26 | -$157.06 | -$321.32 | -$64.26 |
| **Diluted EPS** | -$8.35 | -$41.89 | -$105.11 | -$121.62 | -$130.63 | -$55.26 | -$55.26 | -$157.06 | -$321.32 | -$64.26 |
| Basic Shares Outstanding | 2.6M | 1.2M | 407.0K | 235.0K | 184.9K | 659.8K | 255.6K | 98.6K | 46.7K | 145.4K |
| Diluted Shares Outstanding | 2.6M | 1.2M | 407.0K | 235.0K | 184.9K | 659.8K | 255.6K | 98.6K | 46.7K | 145.4K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $5.44M | $4.56M | $3.01M | $3.16M | $2.52M | $2.39M | $3.43M | $6.21M |
| **Operating Income** | -$8.10M | -$7.20M | -$5.79M | -$5.69M | -$4.85M | -$6.04M | -$6.40M | -$12.74M |
| **EBITDA** | -- | -- | -- | -$5.64M | -$4.80M | -$5.98M | -$6.34M | -$12.68M |
| **Net Income** | -$7.97M | -$6.93M | -$5.65M | -$5.30M | -$4.44M | -$5.45M | -$6.60M | -$2.36M |
| Basic EPS | -$0.46 | -$0.57 | -$1.33 | -- | -$1.41 | -$3.39 | -$4.30 | -- |
| **Diluted EPS** | -$0.46 | -$0.57 | -$1.33 | -- | -$1.41 | -$3.39 | -$4.30 | -- |
| Basic Shares Outstanding | 17.5M | 12.2M | 4.2M | -- | 3.2M | 1.6M | 1.5M | -- |
| Diluted Shares Outstanding | 17.5M | 12.2M | 4.2M | -- | 3.2M | 1.6M | 1.5M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $13.20M | $23.29M | $9.56M | $19.87M | $35.70M | $57.17M | $10.61M | $13.26M | $10.01M | $11.44M |
| **Cash & Short-Term Investments** | $13.20M | $23.29M | $9.56M | $19.87M | $35.70M | $57.17M | $10.61M | $13.26M | $10.01M | $11.44M |
| **Total Current Assets** | $14.04M | $24.25M | $10.45M | $20.53M | $36.57M | $57.94M | $11.39M | $13.95M | $10.47M | $12.19M |
| Property, Plant & Equipment, Net | $549K | $757K | $1.09M | $419K | $344K | $356K | $435K | $543K | $245K | $1.44M |
| Goodwill | -- | -- | -- | -- | -- | -- | $0 | $0 | $1.68M | $1.68M |
| Long-Term Investments | -- | -- | $24K | $75K | $75K | $75K | $75K | $541K | $466K | -- |
| Other Non-Current Assets | $30K | $30K | $30K | $6.2K | $6.2K | $6.2K | $6.2K | $18K | $12K | $12K |
| **Total Non-Current Assets** | $940K | $1.22M | $1.62M | $1.06M | $630K | $720K | $865K | $1.10M | $2.40M | $3.13M |
| **Total Assets** | $14.98M | $25.47M | $12.08M | $21.59M | $37.20M | $58.66M | $12.25M | $15.05M | $12.87M | $15.32M |
| Accounts Payable | $1.44M | $4.11M | $5.62M | $2.56M | $1.42M | $1.43M | $1.28M | $612K | $933K | -- |
| **Total Current Liabilities** | $4.75M | $9.39M | $25.36M | $5.53M | $3.99M | $3.56M | $2.77M | $1.62M | $2.11M | $1.63M |
| **Total Non-Current Liabilities** | $309K | $410K | $494K | $553K | $166K | $302K | $422K | $171K | $2.2K | $152K |
| **Total Liabilities** | $5.06M | $9.80M | $25.85M | $6.08M | $4.16M | $3.86M | $3.19M | $1.79M | $2.12M | $1.78M |
| **Total Debt (incl. Leases)** | $410K | $494K | $553K | $604K | $302K | $422K | $528K | $2.2K | -- | -- |
| Common Stock | $42 | $15 | $207 | $94 | $61 | $454 | $94 | $47 | $16 | $104 |
| Retained Earnings | -$269.1M | -$247.3M | -$202.8M | -$179.5M | -$150.9M | -$126.8M | -$111.7M | -$97.59M | -$84.35M | -$70.79M |
| **Total Stockholders' Equity** | $8.54M | $14.29M | -$15.16M | $8.15M | $33.05M | $54.79M | $9.06M | $13.26M | $10.75M | $13.54M |
| Total Equity | $8.54M | $14.29M | -$15.16M | $8.15M | $33.05M | $54.79M | $9.06M | $13.26M | $10.75M | $13.54M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $24.58M | $33.99M | $8.35M | $13.20M | $12.55M | $11.04M | $13.91M | $23.29M |
| **Cash & Short-Term Investments** | $24.58M | $33.99M | $8.35M | $13.20M | $12.55M | $11.04M | $13.91M | $23.29M |
| **Total Current Assets** | $25.71M | $34.88M | $9.27M | $14.04M | $13.62M | $12.62M | $14.89M | $24.25M |
| Property, Plant & Equipment, Net | $269K | $304K | $340K | $549K | $595K | $648K | $701K | $757K |
| Other Non-Current Assets | $95K | $24K | $30K | $30K | $30K | $30K | $30K | $30K |
| **Total Non-Current Assets** | $4.03M | $1.76M | $1.85M | $940K | $1.01M | $1.08M | $1.15M | $1.22M |
| **Total Assets** | $29.74M | $36.64M | $11.12M | $14.98M | $14.63M | $13.70M | $16.04M | $25.47M |
| Accounts Payable | -- | -- | -- | $1.44M | -- | -- | -- | $4.11M |
| **Total Current Liabilities** | $5.80M | $5.24M | $4.87M | $4.75M | $4.91M | $5.87M | $6.02M | $9.39M |
| **Total Non-Current Liabilities** | $1.53M | $1.53M | $1.53M | $309K | $336K | $361K | $386K | $410K |
| **Total Liabilities** | $7.33M | $6.77M | $6.40M | $5.06M | $5.25M | $6.23M | $6.41M | $9.80M |
| **Total Debt (incl. Leases)** | $1.53M | $1.53M | $1.53M | $410K | $433K | $454K | $476K | $494K |
| Common Stock | $100 | $83 | $42 | $42 | $32 | $18 | $461 | $15 |
| Retained Earnings | -$289.7M | -$281.7M | -$274.8M | -$269.1M | -$263.8M | -$259.4M | -$253.9M | -$247.3M |
| **Total Stockholders' Equity** | $22.42M | $29.87M | $3.34M | $8.54M | $8.00M | $6.09M | $8.25M | $14.29M |
| Total Equity | $22.42M | $29.87M | $3.34M | $8.54M | $8.00M | $6.09M | $8.25M | $14.29M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$21.79M | -$44.58M | -$42.77M | -$28.60M | -$24.12M | -$15.09M | -$14.09M | -$13.24M | -$13.56M | -$6.18M |
| Depreciation & Amortization | $214K | $292K | $192K | $148K | $150K | $141K | $133K | $82K | $1.55M | $357K |
| Stock-Based Compensation | $2.26M | $4.27M | $2.41M | $1.45M | $1.12M | $468K | $867K | $721K | $759K | $529K |
| **Operating Cash Flow** | -$23.12M | -$47.58M | -$32.38M | -$25.22M | -$22.57M | -$13.93M | -$11.69M | -$11.44M | -$11.02M | -$8.28M |
| Capital Expenditure | -$5.9K | -$104K | -$864K | -$226K | -$141K | -$62K | -$25K | -$385K | -$347K | -$72K |
| **Free Cash Flow** | -$23.12M | -$47.69M | -$33.24M | -$25.45M | -$22.71M | -$14.00M | -$11.72M | -$11.83M | -$11.37M | -$8.35M |
| **Investing Cash Flow** | -$5.9K | -$104K | -$864K | -$226K | -$141K | -$62K | -$25K | -$330K | -$347K | -$72K |
| Common Stock Issued | -- | -- | -- | $9.61M | $35K | $59.72M | $9.02M | $9.08M | $4.91M | $12.36M |
| **Financing Cash Flow** | $13.03M | $61.41M | $22.94M | $9.61M | $1.25M | $60.55M | $9.02M | $15.02M | $9.93M | $15.94M |
| **Net Change in Cash** | -$10.09M | $13.72M | -$10.30M | -$15.84M | -$21.46M | $46.55M | -$2.70M | $3.25M | -$1.44M | $7.59M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.97M | -$6.93M | -$5.65M | -$5.30M | -$4.44M | -$5.45M | -$6.60M | -$2.36M |
| Depreciation & Amortization | -- | -- | -- | $49K | $52K | $56K | $56K | $69K |
| Stock-Based Compensation | $518K | $428K | $452K | $568K | $568K | $565K | $563K | $1.49M |
| **Operating Cash Flow** | -$9.41M | -$6.01M | -$4.85M | -$4.34M | -$4.28M | -$5.12M | -$9.38M | -$10.91M |
| Capital Expenditure | $0 | $0 | -$3.4K | -- | -- | -- | -- | -$61K |
| **Free Cash Flow** | -$9.41M | -$6.01M | -$4.85M | -- | -- | -- | -- | -$10.97M |
| **Investing Cash Flow** | $0 | $0 | -$3.4K | -- | -- | -- | -- | -$61K |
| **Financing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Change in Cash** | -$9.41M | $25.65M | -$4.85M | $642K | $1.51M | -$2.86M | -$9.38M | -$10.97M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -255.2% | -311.9% | -- | -350.8% | -73.0% | -27.5% | -155.6% | -99.8% | -126.1% | -45.6% |
| Return on Assets (ROA) | -145.5% | -175.0% | -354.2% | -132.5% | -64.8% | -25.7% | -115.0% | -87.9% | -105.4% | -40.3% |
| Current Ratio | 2.96x | 2.58x | 0.41x | 3.71x | 9.16x | 16.26x | 4.11x | 8.60x | 4.95x | 7.47x |
| Quick Ratio | 2.78x | 2.48x | 0.38x | 3.59x | 8.95x | 16.04x | 3.83x | 8.17x | 4.73x | 7.01x |
| Debt to Equity | 0.05x | 0.03x | -- | 0.07x | 0.01x | 0.01x | 0.06x | 0.00x | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -115.3% | -74.7% | -624.9% | -255.2% | -235.7% | -477.8% | -297.4% | -311.9% |
| Return on Assets (ROA) | -86.9% | -60.9% | -187.4% | -145.5% | -128.9% | -212.3% | -153.0% | -175.0% |
| Current Ratio | 4.44x | 6.66x | 1.90x | 2.96x | 2.77x | 2.15x | 2.47x | 2.58x |
| Quick Ratio | 4.24x | 6.49x | 1.71x | 2.78x | 2.56x | 1.88x | 2.31x | 2.48x |
| Debt to Equity | 0.07x | 0.05x | 0.46x | 0.05x | 0.05x | 0.07x | 0.06x | 0.03x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
